Profile
Myriam Mendila currently works at CureVac NV, as Chief Scientific Officer, Head-R&D.
Dr. Mendila also formerly worked at Novartis Pharma AG, as Chief Medical Officer-Oncology.
Dr. Mendila received her doctorate degree from Hannover Medical School.
Myriam Mendila active positions
| Companies | Position | Start |
|---|---|---|
| CUREVAC | Chief Tech/Sci/R&D Officer | - |
Former positions of Myriam Mendila
| Companies | Position | End |
|---|---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | - |
Training of Myriam Mendila
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Hannover Medical School
Hannover Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
CureVac NV
CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
- Stock Market
- Insiders
- Myriam Mendila
















